0001209191-23-041189.txt : 20230705 0001209191-23-041189.hdr.sgml : 20230705 20230705170512 ACCESSION NUMBER: 0001209191-23-041189 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20230630 FILED AS OF DATE: 20230705 DATE AS OF CHANGE: 20230705 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Pinto Shelly CENTRAL INDEX KEY: 0001857740 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-39386 FILM NUMBER: 231070361 MAIL ADDRESS: STREET 1: 866 MALCOLM ROAD, SUITE 100 CITY: BURLINGAME STATE: CA ZIP: 94010 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: ALX ONCOLOGY HOLDINGS INC CENTRAL INDEX KEY: 0001810182 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 850642577 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 BUSINESS PHONE: 650-466-7125 MAIL ADDRESS: STREET 1: 323 ALLERTON AVENUE CITY: SOUTH SAN FRANCISCO STATE: CA ZIP: 94080 4 1 doc4.xml FORM 4 SUBMISSION X0407 4 2023-06-30 0 0001810182 ALX ONCOLOGY HOLDINGS INC ALXO 0001857740 Pinto Shelly C/O ALX ONCOLOGY HOLDINGS INC. 323 ALLERTON AVENUE SOUTH SAN FRANCISCO CA 94080 0 1 0 0 VP, Finance and CAO 0 Common Stock 2023-06-30 4 S 0 466 7.34 D 63058 D The reported shares were sold to satisfy the reporting person's tax obligations in connection with the vesting of restricted stock units. Includes 1,427 shares acquired under the Issuer's employee stock purchase plan on June 30, 2023. /s/ Peter Garcia, by power of attorney 2023-07-05